LH today
$372.23+$1.35 (+0.36%)close Nov 11, 2026Trend
DailyUptrend (confirmed)
4 hourStrong Bullish
1 hourBullish
15 minBullish
5 minConsolidating
Daily trend turns down below $314.69
Key levels
Support$371.00
Support$341.40
Latest news & SEC filings
SEC FilingLabcorp Holdings Inc. filed an insider trading report (Form 4)
DealLabcorp Venture Fund joins Nanopath financing round
AnalystLabcorp Raised to Buy Rating by HSBC
All LH news →About Labcorp
Labcorp provides clinical laboratory testing and drug development services worldwide. Its Diagnostics segment offers routine and specialty testing, including oncology, women's health, autoimmune, and neurology tests, through patient service centers and in-office phlebotomy. Its Biopharma Laboratory Services segment supports pharmaceutical, biotechnology, and medical device companies with central laboratory and early development research. Customers include physicians, hospitals, health plans, government programs, patients, and biopharma firms.
Based on the company's 10-K filed Feb 24, 2026.
NYSE · Healthcare
LABCORP HOLDINGS INC. (LH)
What Is the Price Target for LH?
SEPT Low Target
$300.00
SEPT Mid Target
$360.00
SEPT High Target
$420.00
Analyst Consensus
$360.00
Is LH a Buy or Sell Right Now?
Thesis
- •Revenue growing 7.2% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for LH.
Start Free Trial →Is LH Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, PEG, Analyst Consensus
Fair Value
$355.52
46
Moat Score
NARROW
8/9
Piotroski Score
3.6
Altman Z-Score
What Is Smart Money Doing with LH?
Insider Signal
SELLING
0 buys / 8 sells (90d)
Congress Signal
BUYING
14 buys / 6 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Vaughn Bryan T | officer | Sale | 306 | $108K | Nov 3, 2026 |
| Oyegunwa Akinbolade | officer | Sale | 118 | $42K | Nov 2, 2026 |
| Vaughn Bryan T | officer | Sale | 194 | $69K | Nov 2, 2026 |
| Oyegunwa Akinbolade | officer | Buy | 370 | - | Nov 1, 2026 |
| Vaughn Bryan T | officer | Buy | 500 | - | Nov 1, 2026 |
| Parham Richelle P | director | Sale | 1,078 | $389K | Oct 30, 2026 |
| Kyle Kathryn W | officer | Sale | 762 | $201K | Jun 8, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →LH Growth Story
Revenue YoY
7.3%
3yr Revenue CAGR
5.5%
EPS Growth YoY
18.33%
FCF Growth YoY
10.1%
Revenue Trend
ACCELERATING
Dark Pool Trades for LH
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for LH, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 22:25:52 | $372.23 | 76,920 | $$28.6M | BUY |
| 22:25:08 | $372.23 | 29,169 | $$10.9M | BUY |
| 21:28:26 | $372.23 | 1,269 | $$472K | BUY |
| 15:29:47 | $371.43 | 1,113 | $$413K | BUY |
| 15:29:03 | $371.31 | 1,300 | $$483K | SELL |
5 dark pool trades shown · $$40.9M preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for LABCORP HOLDINGS INC. (LH) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →LH — frequently asked questions
What is LH stock price today?
LABCORP HOLDINGS INC. (LH) is at $372.23, up 0.36% (+$1.35) at the Nov 11, 2026 close.
Why is LH stock moving today?
Latest LH news — Nov 12, 2026: Labcorp Holdings Inc. filed an insider trading report (Form 4) · Nov 10, 2026: Labcorp Venture Fund joins Nanopath financing round
Why did LH stock move on Oct 15, 2026?
Labcorp (LH) shares closed at $325.07, up 1.11% on volume of 453,992, as the company announced it has agreed to acquire select assets of OPKO Health's BioReference Health subsidiary for $722 million in cash, plus up to an additional $150 million in earnout tied to revenue. The deal, reported across multiple headlines, was framed as a major merger move for Labcorp and was met with bullish sentiment.
What is the LH price target?
The average analyst price target for LH is $360.00, ranging from $300 to $420, based on 9 analysts.
What do analysts rate LH?
Analyst ratings for LH: 1 Buy, 17 Hold, 0 Sell — consensus Hold.
Did LH beat earnings?
LH last reported on Oct 28, 2026: EPS $4.78 vs $4.64 expected — a beat of 3.0%.
What is LH's P/E ratio?
LH trades at a P/E of 30.5 vs a Healthcare average of 17.7.
Does LH pay a dividend?
Yes. LH's dividend yield is 1.15%.
What are LH support and resistance levels?
Support: $371.00, $341.40, $327.50.
What are insiders doing with LH?
Insider activity: SELLING, 0 buys and 8 sells in the last 90 days.
What is the latest news on LH?
Nov 12, 2026: Labcorp Holdings Inc. filed an insider trading report (Form 4) · Nov 10, 2026: Labcorp Venture Fund joins Nanopath financing round · Nov 5, 2026: Labcorp Raised to Buy Rating by HSBC